N. Bosch

Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer

F. Papaccio, A. Cervantes, M. Civera, 2018, ESMO Open.

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study

A. Segura‐Carretero, S. Verdura, E. Cuyás, 2018, Oncotarget.

Abstract P1-10-01: Safety and efficacy of neoadjuvant metformin with trastuzumab and chemotherapy in women with HER2-positive early breast cancer: A randomized, open-label, multicenter, phase 2 trial

S. Verdura, E. Cuyás, E. López-Bonet, 2018 .